LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

Intrinsic Value

The intrinsic value of one LVTX stock under the Base Case scenario is 2.55 USD. Compared to the current market price of 1.74 USD, LAVA Therapeutics NV is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LVTX Intrinsic Value
2.55 USD
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
LAVA Therapeutics NV

What is Valuation History?
Ask AI Assistant
What other research platforms think about LVTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LVTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for LAVA Therapeutics NV.

Explain Valuation
Compare LVTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LVTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
LAVA Therapeutics NV

Current Assets 69.8m
Cash & Short-Term Investments 66.6m
Other Current Assets 3.2m
Non-Current Assets 1.4m
PP&E 1.3m
Other Non-Current Assets 95k
Current Liabilities 10.4m
Accounts Payable 1.5m
Accrued Liabilities 7.2m
Other Current Liabilities 1.7m
Non-Current Liabilities 35m
Other Non-Current Liabilities 35m
Efficiency

Free Cash Flow Analysis
LAVA Therapeutics NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
LAVA Therapeutics NV

Revenue
12m USD
Operating Expenses
-69.9m USD
Operating Income
-57.9m USD
Other Expenses
8.7m USD
Net Income
-49.2m USD
Fundamental Scores

LVTX Profitability Score
Profitability Due Diligence

LAVA Therapeutics NV's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
12/100
Profitability
Score

LAVA Therapeutics NV's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

LVTX Solvency Score
Solvency Due Diligence

LAVA Therapeutics NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

LAVA Therapeutics NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LVTX Price Targets Summary
LAVA Therapeutics NV

Wall Street analysts forecast LVTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LVTX is 1.4 USD with a low forecast of 1.25 USD and a high forecast of 1.58 USD.

Lowest
Price Target
1.25 USD
28% Downside
Average
Price Target
1.4 USD
20% Downside
Highest
Price Target
1.58 USD
9% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

LAVA Therapeutics NV
does not pay dividends
Shareholder Yield

Current shareholder yield for LVTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LVTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LVTX stock?

The intrinsic value of one LVTX stock under the Base Case scenario is 2.55 USD.

Is LVTX stock undervalued or overvalued?

Compared to the current market price of 1.74 USD, LAVA Therapeutics NV is Undervalued by 32%.

Back to Top